Abstract
Gram-positive cocci are responsible for many severe infections in community and hospital settings, and these multidrug resistant organisms have increased markedly in the past decade. This trend is particularly evident for methicillin/ oxacillin-resistant Staphylococcus aureus (MRSA). MRSA is any strain of Staphylococcus aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. S. aureus strains have developed resistance to almost all antibiotics, thereby complicating disease management. Antibiotics are an essential part of modern medicine and that has helped dramatically in curing patients suffering from bacterial infections. However, emerging antimicrobial resistance in bacteria threatens to undermine the management of bacterial infections. A number of factors, which may promote antimicrobial resistance such as availability of antimicrobials without prescription, suboptimal hygiene, immunosuppression due to malnutrition or HIV, aggressive cancer chemotherapy and an increase in organ transplantation have resulted in hospitalized patients with immune compromise at high risk of nosocomial infections. The emergence of antibiotic-resistant mutants among bacteria is seemingly inevitable, that results in the decreased efficacy and withdrawal of the antibiotic from wide-spread usage. The purpose of this review is to discuss the increase in isolates of multidrug resistant S. aureus which has created an urgent need for the development of new anti-staphylococcal agents.
Keywords: Staphylococcus aureus, MRSA, antibiotics, mechanism of resistance
Anti-Infective Agents
Title:Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections
Volume: 10 Issue: 2
Author(s): Harsha Patel, Yogeshkumar Vaghasiya, BRM Vyas and Sumitra Chanda
Affiliation:
Keywords: Staphylococcus aureus, MRSA, antibiotics, mechanism of resistance
Abstract: Gram-positive cocci are responsible for many severe infections in community and hospital settings, and these multidrug resistant organisms have increased markedly in the past decade. This trend is particularly evident for methicillin/ oxacillin-resistant Staphylococcus aureus (MRSA). MRSA is any strain of Staphylococcus aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. S. aureus strains have developed resistance to almost all antibiotics, thereby complicating disease management. Antibiotics are an essential part of modern medicine and that has helped dramatically in curing patients suffering from bacterial infections. However, emerging antimicrobial resistance in bacteria threatens to undermine the management of bacterial infections. A number of factors, which may promote antimicrobial resistance such as availability of antimicrobials without prescription, suboptimal hygiene, immunosuppression due to malnutrition or HIV, aggressive cancer chemotherapy and an increase in organ transplantation have resulted in hospitalized patients with immune compromise at high risk of nosocomial infections. The emergence of antibiotic-resistant mutants among bacteria is seemingly inevitable, that results in the decreased efficacy and withdrawal of the antibiotic from wide-spread usage. The purpose of this review is to discuss the increase in isolates of multidrug resistant S. aureus which has created an urgent need for the development of new anti-staphylococcal agents.
Export Options
About this article
Cite this article as:
Patel Harsha, Vaghasiya Yogeshkumar, Vyas BRM and Chanda Sumitra, Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020149
DOI https://dx.doi.org/10.2174/2211362611208020149 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Triple-Valve Endocarditis in a Diabetic Patient: Case Report and Literature Review
Current Cardiology Reviews Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews The Relationship Between HIV Infection and Cardiovascular Disease
Current Cardiology Reviews Recent Developments in Antithrombotic Therapy: Will Sodium Warfarin Be a Drug of the Past?
Recent Patents on Cardiovascular Drug Discovery Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Pharmacogenomics and Severe Infections: The Role of the Genomes of Both the Host and the Pathogen
Current Pharmacogenomics Comparative Time-Kill Study of Doxycycline, Tigecycline, Cefazolin and Vancomycin Against Several Clones of Staphylococcus aureus
Current Clinical Pharmacology Perceval Sutureless Valve – are Sutureless Valves Here?
Current Cardiology Reviews Waste Material of Propolis as a Film Forming Agent Intended to Modify the Metronidazole Release: Preparation and Characterization
Current Drug Delivery Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
Current Topics in Medicinal Chemistry Current Solutions for the Interception of Quorum Sensing in Staphylococcus aureus
Current Organic Chemistry Dendrimers and Dendritic Polymers as Anti-infective Agents: New Antimicrobial Strategies for Therapeutic Drugs
Anti-Infective Agents in Medicinal Chemistry Bacterial Adaptation and Infection
Inflammation & Allergy - Drug Targets (Discontinued) Linezolid in Children: Recent Patents and Advances
Recent Patents on Anti-Infective Drug Discovery Vaccine Therapy for P. acnes-Associated Diseases
Infectious Disorders - Drug Targets Immunoinformatic Approach for the Identification of Potential Epitopes Against <i>Stenotrophomonas maltophilia</i>: A Global Opportunistic Pathogen
Letters in Drug Design & Discovery Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology Thoracic Aortic Aneurysm: Blood Pressure and Inflammation as Key Factors in the Development of Aneurysm Dissection
Current Pharmaceutical Design